Please check your email for the verification action. You may continue to use the site and you are now logged in, but you will not be able to return to the site in future until you confirm your email address.
Aims. The diagnosis of periprosthetic joint infection can be difficult
due to the high rate of culture-negativeinfections. The aim of
this study was to assess the use of next-generation sequencing for
detecting organisms in synovial fluid. Materials and Methods. In this prospective, single-blinded study, 86 anonymized samples
of synovial fluid were obtained from patients undergoing aspiration
of the hip or knee as part of the investigation of a periprosthetic
infection. A panel of synovial fluid tests, including levels of
C-reactive protein, human neutrophil elastase, total neutrophil
count, alpha-defensin, and culture were performed prior to next-generation
sequencing. Results. Of these 86 samples, 30 were alpha-defensin-positive and culture-positive
(Group I), 24 were alpha-defensin-positive and culture-negative
(Group II) and 32 were alpha-defensin-negative and culture-negative
(Group III). Next-generation sequencing was concordant with 25 results
for Group I. In four of these, it detected antibiotic resistant bacteria
whereas culture did not. In another four samples with relatively
low levels of inflammatory biomarkers, culture was positive but
next-generation sequencing was negative. A total of ten samples had a positive next-generation sequencing
result and a negative culture. In five of these, alpha-defensin
was positive and the levels of inflammatory markers were high. In
the other five, alpha-defensin was negative and the levels of inflammatory
markers were low. While next-generation sequencing detected several organisms
in each sample, in most samples with a higher probability of infection,
there was a predominant organism present, while in those presumed
not to be infected, many organisms were identified with no predominant
organism. Conclusion. Pathogens causing periprosthetic infection in both culture-positive
and culture-negative samples of synovial fluid could be identified
by next-generation sequencing. Cite this article: Bone Joint J 2018;100-B:127–33